InsidersTradesSigma
Track the AKUMIN INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, AKUMIN INC. has logged 28 reports. The latest transaction was filed on 18 July 2023 (Attribution). Among the most active insiders: KRETSCHMER R. DAVID. All data is openly available.
28
Insider Decl.
n/a
Thresholds
€22,989
3 ops.
Buy Volume
€2m
4 ops.
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 July 2023
Declarations28 total
250,000 shares0Common StockSEC:0001982285-23-000006:0
102,459 shares0Common StockSEC:0000899243-23-011101:0
102,459 shares0Common StockSEC:0000899243-23-011105:0
102,459 shares0Common StockSEC:0000899243-23-011091:0
102,459 shares0Common StockSEC:0000899243-23-011107:0
102,459 shares0Common StockSEC:0000899243-23-011100:0
102,459 shares0Common StockSEC:0000899243-23-011106:0
700,000 shares0Common StockSEC:0000899243-23-011094:0
150,000 shares0Common StockSEC:0000899243-23-011090:0
150,000 shares0Common StockSEC:0000899243-23-011096:0
102,459 shares0Common StockSEC:0000899243-23-011097:0
57,078 sharesCommon StockSEC:0000899243-23-010067:0
250,000 shares0Common StockSEC:0000899243-23-005388:0
100,000 shares0Common StockSEC:0000899243-23-000328:0
150,000 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-22-038040:0
6,500 shares@ US$1.37844.2% of flowCommon StockSEC:0000899243-22-030107:0
Canonical exit: 27 Nov 2022 (T+90)
2,519 shares@ US$1.10100.0% of flowCommon StockSEC:0000899243-22-029489:0
Canonical exit: 16 Nov 2022 (T+90)
10,000 shares@ US$1.1455.8% of flowCommon StockSEC:0000899243-22-029491:0
Canonical exit: 16 Nov 2022 (T+90)
3,065,257 shares@ US$0.5287.4% of flowCommon SharesSEC:0000899243-22-026606:0
114,155 shares0Common StockSEC:0000899243-22-013391:0
114,155 shares0Common StockSEC:0000899243-22-013386:0
114,155 shares0Common StockSEC:0000899243-22-013388:0
114,155 shares0Common StockSEC:0000899243-22-013392:0
114,155 shares0Common StockSEC:0000899243-22-013394:0
114,155 shares0Common StockSEC:0000899243-22-013385:0
25 of 28 declarations
关于 AKUMIN INC.
Akumin Inc. 是一家在美国纳斯达克上市的美国医疗保健服务公司，专注于门诊诊断影像及相关服务。对于讲法语的投资者而言，该公司处于医疗保健领域中一个相对防御性但运营敏感的细分市场，其需求由筛查、后续护理和专业诊断驱动。Akumin 运营独立的影像中心，通过在门诊环境中提供放射学和诊断解决方案，为医生、医院和医疗系统提供服务。([akumin.com](https://akumin.com/wp-content/uploads/2020-Q4-Annual-Information-Form-20210331-vF.pdf?utm_source=openai)) 从历史角度看，Akumin 围绕影像资产和临床工作流程优化构建其平台，其业务重心一直放在美国市场。公司文件将 Akumin 描述为美国领先的门诊诊断影像服务提供商，其总部位于佛罗里达州普兰泰申，这巩固了其在美国东南部的运营基地。([akumin.com](https://akumin.com/wp-content/uploads/2020-Q4-Annual-Information-Form-20210331-vF.pdf?utm_source=openai)) 其商业模式主要围绕独立影像设施的运营以及提供诊断放射服务，如 MRI、CT、X 射线、超声波和其他专业影像模式。这种模式是资本密集型的，需要对先进设备、技术人员和法规遵从进行大量投资。同时，它受益于人口老龄化、慢性病管理以及早期诊断日益重要所带来的持久潜在需求。Akumin 的门诊重点也可以成为相对于医院影像的竞争优势，为患者和转诊医生提供更大的灵活性和可能更低的访问点。([akumin.com](https://akumin.com/wp-content/uploads/2020-Q4-Annual-Information-Form-20210331-vF.pdf?utm_source=openai)) 在竞争方面，Akumin 在一个分散的市场中运营，该市场包括医院系统、区域影像集团和独立的门诊运营商。公司的价值主张基于可及性、地理邻近性以及提供方便患者和高效转诊的诊断服务的能力。对于投资者而言，关键考虑因素是利用率、报销动态、运营效率以及与支付方和医生网络的合作关系强度。([akumin.com](https://akumin.com/wp-content/uploads/2020-Q4-Annual-Information-Form-20210331-vF.pdf?utm_source=openai)) 最近的公开披露和 SEC 相关文件表明，Akumin 在内幕交易和市场治理方面持续受到关注，这对于一家上市的医疗保健微/小盘公司而言是典型的。该公司在纳斯达克上市增强了其在美国医疗保健服务领域的知名度，使其成为在基本面和事件驱动型投资者筛选中都可能出现的公司。([akumin.com](https://akumin.com/wp-content/uploads/Akumin-2021-Management-Information-Circular-vF.pdf?utm_source=openai))
